Some researchers have indicated that the ApoB/ApoA-I ratio is the strongest indicator of the risk of CVD and may be particularly useful in assessing its risk in metabolic syndrome, even when concentrations of LDL are generally not elevated [29]. This evidence concerns the gene APOA1 and metabolic syndrome.